Azakem Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.40 Cr
as on 23-10-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 7.45 M
as on 23-10-2024
- Revenue 89.28%
(FY 2023)
- Profit 424.20%
(FY 2023)
- Ebitda 423.22%
(FY 2023)
- Net Worth 17.07%
(FY 2023)
- Total Assets 38.59%
(FY 2023)
About Azakem Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹7.45 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasulu Kavuturu, Kangani Cyrous, Satish Bethini, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2005PTC048093
- Company No.
048093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Azakem Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasulu Kavuturu  | Managing Director | 23-Aug-2006 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kangani Cyrous  | Director | 27-May-2022 | Current |
| Satish Bethini | Director | 30-Mar-2021 | Current |
| Ramesh Betini | Director | 31-Oct-2020 | Current |
| Kavuturu Harshavardhan | Director | 31-Oct-2020 | Current |
Financial Performance of Azakem Labs.
Azakem Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 89.28% increase. The company also saw a substantial improvement in profitability, with a 424.2% increase in profit. The company's net worth Soared by an impressive increase of 17.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azakem Labs?
In 2023, Azakem Labs had a promoter holding of 82.53% and a public holding of 17.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Petro Batis Chemicals & Equipment Private LimitedActive 11 years 6 months
Kangani Cyrous is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 19 Jan 2009 | ₹1.00 Cr | Open |
Andhra Bank Creation Date: 15 Mar 2010 | ₹1.45 M | Satisfied |
Andhra Bank Creation Date: 19 Jan 2009 | ₹6.00 M | Satisfied |
How Many Employees Work at Azakem Labs?
Azakem Labs has a workforce of 80 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azakem Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azakem Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
